Arrowhead Pharmaceuticals, Inc.

MetLife Investment Management, LLC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

73,040

Value ($000)

4,849

Weight

0.0%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	4,849	0.0%	73,040	12/31/2025
2025 Q3	11/13/2025	2,482	0.0%	71,963	9/30/2025
2025 Q2	8/13/2025	1,137	0.0%	71,963	6/30/2025
2025 Q1	5/14/2025	917	0.0%	71,963	3/31/2025
2024 Q4	2/13/2025	2,651	0.0%	141,011	12/31/2024
2024 Q3	11/13/2024	2,538	0.0%	131,029	9/30/2024
2024 Q2	8/13/2024	3,434	0.0%	132,131	6/30/2024
2024 Q1	5/14/2024	3,600	0.0%	125,882	3/31/2024
2023 Q4	4/22/2024	3,452	0.0%	112,823	12/31/2023
2023 Q3	5/9/2024	3,057	0.0%	113,771	9/30/2023
2023 Q2	4/29/2024	4,151	0.0%	116,412	6/30/2023
2023 Q1	5/9/2024	3,005	0.0%	118,296	3/31/2023
2022 Q4	5/10/2024	4,810	0.0%	118,579	12/31/2022
2022 Q3	5/10/2024	3,963	0.0%	119,924	9/30/2022
2022 Q2	5/10/2024	4,248	0.0%	120,656	6/30/2022
2022 Q1	5/10/2024	5,529	0.0%	120,217	3/31/2022
2021 Q4	5/17/2024	5,657	0.0%	85,326	12/31/2021
2021 Q3	5/17/2024	5,374	0.0%	86,086	9/30/2021
2021 Q2	5/17/2024	7,289	0.1%	88,008	6/30/2021
2021 Q1	5/17/2024	6,061	0.1%	91,401	3/31/2021
2020 Q4	5/24/2024	7,382	0.1%	96,209	12/31/2020
2020 Q3	5/24/2024	4,334	0.0%	100,641	9/30/2020
2020 Q2	5/24/2024	4,519	0.1%	104,622	6/30/2020
2020 Q1	7/12/2023	2,875	0.0%	99,934	3/31/2020
2019 Q4	7/12/2023	6,151	0.1%	96,976	12/31/2019
2019 Q3	7/12/2023	1,154	0.0%	40,960	9/30/2019
2019 Q2	7/12/2023	1,085	0.0%	40,960	6/30/2019
2019 Q1	7/13/2023	752	0.0%	40,960	3/31/2019
2018 Q4	7/13/2023	509	0.0%	40,960	12/31/2018
2018 Q3	7/13/2023	785	0.0%	40,960	9/30/2018